TREM2 and neoplasm: “T cell” neighborhoods enriched with effector T cells and mature macrophages that lacked tumor epithelium lie immediately adjacent to drug-sensitive proliferating BCC surrounded by TREM2 + VCAM1+ myeloid cells or resistant BIT tumors surrounded by lymphocyte-poor TREM1+ myeloid-driven inflammation.